Medicare

Commentary

Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives

This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Business & Economics

Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy

On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Commentary

Democratic 2020 Hopefuls: All Roads Lead To Single-Payer

The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Commentary

Don’t blame drug companies for high prices

*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
Commentary

You should absolutely believe Kamala Harris: ‘Medicare for All’ will kill your health insurance

Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can’t do that outright, she’s happy settling for a reform that will eventually take away private health coverage. Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her proposal for the healthcare ...
Business & Economics

Fostering Transparency In The Pharmaceutical Market

In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Business & Economics

Medicare price controls would harm patients and workers

Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, the ...
Blog

New Polling Shows Free Market Ideas Still Hold Sway in Liberal California

The first weeks of 2019 have been dominated by the push from emboldened Sacramento liberals to enact measures increasing our tax burden, imposing new regulations on employers, and taking away some of our personal freedom. Most observers argue, based on the massive 2018 Democrat victories, that voters were giving a ...
Commentary

Washington’s rude healthcare awakening

Washington state Gov. Jay Inslee wants to create a state-run health insurance plan to compete against private coverage on the Evergreen State’s Obamacare exchange. This plan, known as a “public option,” is a terrible idea. It’d be a boondoggle for taxpayers and open the door to a future single-payer system. Inslee claims a public ...
Health Care

Sally Pipes Shares Truth About Single-Payer on Bill Martinez Live

PRI President, CEO, and Thomas W. Smith Fellow in Healthcare Policy Sally C. Pipes shares the truth about Medicare-for-All on the national “Bill Martinez Live” program.
Commentary

Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives

This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Business & Economics

Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy

On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Commentary

Democratic 2020 Hopefuls: All Roads Lead To Single-Payer

The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Commentary

Don’t blame drug companies for high prices

*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
Commentary

You should absolutely believe Kamala Harris: ‘Medicare for All’ will kill your health insurance

Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can’t do that outright, she’s happy settling for a reform that will eventually take away private health coverage. Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her proposal for the healthcare ...
Business & Economics

Fostering Transparency In The Pharmaceutical Market

In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Business & Economics

Medicare price controls would harm patients and workers

Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, the ...
Blog

New Polling Shows Free Market Ideas Still Hold Sway in Liberal California

The first weeks of 2019 have been dominated by the push from emboldened Sacramento liberals to enact measures increasing our tax burden, imposing new regulations on employers, and taking away some of our personal freedom. Most observers argue, based on the massive 2018 Democrat victories, that voters were giving a ...
Commentary

Washington’s rude healthcare awakening

Washington state Gov. Jay Inslee wants to create a state-run health insurance plan to compete against private coverage on the Evergreen State’s Obamacare exchange. This plan, known as a “public option,” is a terrible idea. It’d be a boondoggle for taxpayers and open the door to a future single-payer system. Inslee claims a public ...
Health Care

Sally Pipes Shares Truth About Single-Payer on Bill Martinez Live

PRI President, CEO, and Thomas W. Smith Fellow in Healthcare Policy Sally C. Pipes shares the truth about Medicare-for-All on the national “Bill Martinez Live” program.
Scroll to Top